| PECAX | VMCIX | PECAX / VMCIX | |
| Total Expense Ratio | 1.09 | 0.03 | 3,633% |
| Annual Report Gross Expense Ratio | 1.21 | 0.03 | 4,033% |
| Fund Existence | 34 years | 28 years | - |
| Gain YTD | 3.022 | 10.603 | 29% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 220M | 226B | 0% |
| Annual Yield % from dividends | 0.15 | 1.30 | 12% |
| Returns for 1 year | -7.09 | 9.95 | -71% |
| Returns for 3 years | 9.56 | 50.01 | 19% |
| Returns for 5 years | -27.98 | 32.86 | -85% |
| Returns for 10 years | -21.15 | 158.44 | -13% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| QKACX | 57.28 | N/A | N/A |
| Federated Hermes MDT All Cap Core R6 | |||
| VRGWX | 971.17 | N/A | N/A |
| Vanguard Russell 1000 Growth Index I | |||
| MRFOX | 34.94 | N/A | N/A |
| Marshfield Concentrated Opportunity | |||
| MLNCX | 28.50 | N/A | N/A |
| Morgan Stanley Instl Glbl Concntr C | |||
| NSMRX | 39.46 | -0.29 | -0.73% |
| Nuveen Small/Mid-Cap Value I | |||